|
|
Clinical analysis of Pulmonary Consolidation in Children with Mycoplasma Pneumoniae Infection |
LU Sukun, LIU Jianhua, SHUAI Jinfeng, et al |
The Children's Hospital of Hebei Province, Hebei Shijiazhuang 050031, China |
|
|
Abstract Objective: To investigate the clinical diagnosis and treatment of childhood mycoplasma pneumoniae infections with lung consolidation. Methods: Clinical data and treatment of 149 children mycoplasma pneumoniae infections with lung consolidation hospitalized were analyzed retrospectively. Results: (1) All the 149 patients had fever and cough. The average course of disease before admission was 10.7±6.0 days. The average course of disease after admission was 3.87±4.57 days and the average stay was 15.9±6.5 days. Among the 149 children, there were 105 cases with hyperpyrexia; White blood cell (WBC) was normal in 87 cases; Unilateral lung involvement was found in 131 cases; there were 70 cases with Pleural effusion and 5 cases with pulmonary necrosis; And there were 58 preschool children and 75 school-age children, no significant difference was found in sex, maximum body temperature, length of stay, fever duration and complications between the two groups. (2) For the treatment, azithromycin was the first drug and sensitive antibiotics was used if complicated with bacterial infection. And bronchoalveolar Lavage with bronchoscope was indispensable. Moreover, short-period application of glucocorticosteroid on critical patients can effectively improve clinical symptoms. Conclusions: Childhood mycoplasma pneumoniae infections with lung consolidation can occur at all ages and more common at preschool and school age. Its incidence of RMPP is high. White blood cell was normal and Unilateral lung involvement was found in most patients. It was relatively serious and had prolonged course,however,it can be clinically cured with combined modality treatment mostly.
|
|
|
|
|
[1] Jain S,Williams DJ,Arnold SR,et a1.Community-acquired pneumonia requiring hospitalization among U.S.children[J].N Engl Med,2015,372(9):835~845. [2] Liu WK,Liu Q,Chen de H,et a1.Epidemiology of acute respiratory infections in children in Guangzhou:a three-year study[J].PLoS One,2014,9(5):e96674.〖ZK) [3] 王臻,李雅春,陈璐.儿童难治性肺炎支原体肺炎的早期识别[J].中国当代儿科杂志,2015,17(11):1189~1192. [4] Wang Y,Xu D,Li S, et a1.Mycoplasma pneumoniae-associated necrotizing pneumonitis in children[J].Pediatr Int,2012,54(2):293~297. [5] Garcia AV,Fingeret AL,Thirumoorthi AS,et a1.Severe Mycoplasma pneumoniae infection requiring extracorporeal membrane oxygenation with concomitant ischemic stroke in a child[J].Pediatr Pulmonol,2013,48(1):98~101. [6] Tamura A,Matsubara K,Tanaka T,et a1.Methylprednisolone pulse therapy for refractory Mycoplasma pneumoniae pneumonia in children[J].Infect,2008,57(3):223~228. [7] 中华医学会儿科学分会呼吸学组,《中华儿科杂志》编辑委员会.儿童社区获得性肺炎管理指南(2013修订)(上)[J].中华儿科杂志,2013,51(10):745~752. [8] 中华医学会儿科学分会呼吸学组,《中华实用儿科临床杂志》编辑委员会.儿童肺炎支原体肺炎诊治专家共识(2015年版)[J].中华实用儿科临床杂志,2015,30(17):1304~1308. [9] 卢志威,赵辉,郑跃杰等.三种方法对儿童肺炎支原体感染诊断的动态评价[J].临床儿科杂志,2012,30(4):382~385. [10] Harris M,Clark J,Coote N,et a1.British thoracic society guidelines for the management of community acquired pneumonia in children:update 2011[J].Thorax,2011,66(Suppl 2):iil~23 [11] Shimizu T,Kida Y,Kuwano K.Triacylated lipoproteins derived from Mycoplasma pneumoniae activate nuclear factor-kappaB through toll-like receptors 1 and 2[J].Immunology,2007,121(4):473~483. [12] 刘金荣,彭芸,杨海明,等. 难治性肺炎支原体肺炎的表现特征和判断指标探讨[J].中华儿科杂志,2012,50(12):915~918. [13] Narita M.Pathogenesis of extrapulmonary manifestations of mycoplasma pneumoniae infection with special reference to pneumonia[J].Infect Chemother,2010,16(3):162~169. |
|
|
|